SNSE Stock Analysis: Buy, Sell, or Hold?
SNSE - Sensei Biotherapeutics, Inc. Common Stock
$13.85
0.85 (6.54%)
▲
5d:
+6.54%
30d:
-30.12%
90d:
-53.68%
BUY
HIGH Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When SNSE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SNSE shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: SNSE shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: SNSE is currently trading at $13.85, which is considered slightly low relative to its 30-day fair value range of $13.31 to $19.03.
Technical Outlook: Technically, SNSE is in a uptrend. Immediate support is located at $12.35, while resistance sits at $21.50. The stock is showing strong short-term momentum, up 6.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $52.50 (+279.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SNSE is in a uptrend. Immediate support is located at $12.35, while resistance sits at $21.50. The stock is showing strong short-term momentum, up 6.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $52.50 (+279.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$13.31 -
$19.03
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.5%)
- BULLISH: Trading 279.1% below Wall St target ($52.50)
Trading Range Analysis
30-Day Trading Range
$13.31 -
$19.03
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$12.35
Resistance Level
$21.50
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.75
Wall Street Target
$52.50
(+279.1%)
Share & Embed Analysis
Last updated: June 23, 2026 3:53 PM ET
Data refreshes hourly during market hours. Next update: 4:53 PM
Data refreshes hourly during market hours. Next update: 4:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNSE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
